IRA Lawsuits Continue As CMS Approaches Initial Offer Deadline

Nine lawsuits remain in play against Medicare’s new drug price negotiation program as CMS draws closer to submitting its initial pricing offers to participating drug companies on Feb. 1, which will kick off a back-and-forth process through Aug. 1 aimed at lowering the prices for 10 of Part D’s most expensive medicines. One major looming question, Georgetown O’Neill Institute Health Policy and the Law Initiative Director Zachary Baron told Inside Drug Pricing , is whether other judges will fall in...